Holen Sie sich die Stockscreener-App
44.40
0.01%
-0.010
Schlusskurs vom Vortag:
$44.41
Offen:
$44.48
24-Stunden-Volumen:
180.82K
Relative Volume:
0.32
Marktkapitalisierung:
$2.02B
Einnahmen:
$1.23B
Nettoeinkommen (Verlust:
$20.43M
KGV:
100.66
EPS:
0.4411
Netto-Cashflow:
$95.39M
1W Leistung:
+1.33%
1M Leistung:
+18.82%
6M Leistung:
+21.13%
1J Leistung:
+57.30%
1-Tages-Spanne:
$44.00
$44.84
1-Wochen-Bereich:
$42.99
$44.84
52-Wochen-Spanne:
$26.84
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
44.38 | 2.02B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
158.00 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.19 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.69 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.83 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
53.27 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Understanding Momentum Shifts in (OMCL) - Stock Traders Daily
Omnicell Stock Surges 57.3% in a Year: What's Driving It? - Yahoo Finance
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch - Yahoo Finance
Omnicell, Inc.Common Stock (NQ: OMCL - The Chronicle-Journal
Should You Buy Omnicell (OMCL) After Golden Cross? - Yahoo Finance
Why Omnicell Stock Crushed the Market Today - MSN
Omnicell Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Omnicell (OMCL) Issues Recall for Specific Syringe Labels - GuruFocus
Which Is a Better Investment, Axogen, Inc. or Omnicell, Inc. Stock? - AAII
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87% - Yahoo Finance
Omnicell EVP Corey Manley sells $217,180 in OMCL shares By Investing.com - Investing.com South Africa
Omnicell EVP Corey Manley sells $217,180 in OMCL shares - Investing.com
Omnicell (OMCL) COO reports 3,090-share sale and RSU tax withholding - Stock Titan
Omnicell (OMCL) officer has 226 shares withheld to cover RSU taxes - Stock Titan
Omnicell (OMCL) EVP Manley sells 5,025 shares, 4,041 withheld for taxes - Stock Titan
Omnicell (OMCL) CEO uses 12,347 shares to cover RSU tax withholding - Stock Titan
Is Analyst Optimism And Wellington’s Stake Reshaping The Investment Case For Omnicell (OMCL)? - Sahm
OMCL (NASDAQ) director files to sell 5,025 vested shares via Fidelity - Stock Titan
[144] OMNICELL, INC. SEC Filing - Stock Titan
Dana Investment Advisors Inc. Purchases New Shares in Omnicell, Inc. $OMCL - MarketBeat
Omnicell Inc stock (US6821321088): pharmacy automation specialist after latest earnings update - AD HOC NEWS
Omnicell Stock Analysis: Is It a Buy or a Portfolio Risk After 23% Gain?News and Statistics - IndexBox
Omnicell (OMCL) is a great momentum stock: Should you buy? - MSN
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Wellington affiliates hold 5.96% of Omnicell (OMCL) common stock - Stock Titan
OMCL News | OMNICELL INC (NASDAQ:OMCL) - ChartMill
Avoiding Lag: Real-Time Signals in (OMCL) Movement - Stock Traders Daily
Here is What Analysts Are Saying About Omnicell, Inc. (OMCL) - Insider Monkey
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell's (NASDAQ:OMCL) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Omnicell's (NASDAQ:OMCL) Conservative Accounting Might Explain Soft Earnings - simplywall.st
Some Investors May Be Willing To Look Past Omnicell's (NASDAQ:OMCL) Soft Earnings - 富途牛牛
BofA Securities Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $70 - Moomoo
What Can You Expect From Omnicell Inc (OMCL) Stock After Solid Q1? - Insider Monkey
Omnicell (NASDAQ:OMCL) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Omnicell lifts 2026 non-GAAP EPS outlook to $1.80-$2.00 as Titan XT shipments are planned for 2H 2026 - MSN
Q3 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
Q2 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
Vanguard Group Inc. Has $251.55 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Here's why Omnicell (OMCL) is a strong momentum stock - MSN
Pharmacy Automation Systems Market to Get an Explosive Growth | - openPR.com
Is It Time To Reassess Omnicell (OMCL) After Its 71% One Year Share Price Rebound - Yahoo Finance
Omnicell Names Former KU Health System Exec as Its Chief Pharmacy and Clinical Officer - Dallas Innovates
Here's Why Omnicell (OMCL) is a Strong Momentum Stock - Yahoo Finance
Omnicell (NASDAQ: OMCL) returns to profit with stronger Q1 2026 cash flow - Stock Titan
Omnicell | 10-Q: Q1 2026 Earnings Report - Moomoo
Wall Street analysts see a 41.19% upside in Omnicell (OMCL): Can the stock really move this high? - MSN
Omnicell (OMCL) Q1 2026 Earnings Transcript - AOL.com
Omnicell, Inc. Experiences Valuation Adjustment Amid Strong Market Performance Metrics - Markets Mojo
Omnicell (OMCL) Is Up 13.7% After Earnings Beat, Raised Guidance, And Key Pharmacy HireWhat's Changed - Sahm
North America Central Fill Pharmacy Automation Market Growth - openPR.com
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omnicell Inc-Aktie (OMCL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
May 18 '26 |
Sale |
43.22 |
5,025 |
217,180 |
112,783 |
0.64%
1.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):